baber/WOPTO huggingface dataset:
Patent JP-2001518123-A (JP)
Title: 画像保護用透明層
IPC: B41M5/00
Filed: 1996-05-22
Abstract: (57)【要約】
剥離ライナーから画像形成した基板に転写するための透明保護層を開示する。該層は、ビニル樹脂、アクリル樹脂、所望な可塑剤および所望な安定剤を含む組成物を含有する。該層は融解温度にて該画像形成した基板に転写され、次いで該剥離ライナーを除去する。該融解温度は、該画像または該基板に有害な影響を与えない。該画像はいかなる従来の電子的な方法を使用して作成されてもよい。限定されない例には、電子記録方法、電子写真方法、静電的方法、インクジェット印刷方法等が含まれる。該画像は、全て当業者に周知である、染料、顔料、またはトナー、インキもしくはペイントの２者の組み合わせを含有してもよい。
Patent JP-H11503691-A (JP)
IPC: G11B23/03
Filed: 1996-04-12
Abstract: PCT No. PCT/AU96/00221 Sec. 371 Date Oct. 10, 1997 Sec. 102(e) Date Oct. 10, 1997 PCT Filed Apr. 12, 1996 PCT Pub. No. WO96/32719 PCT Pub. Date Oct. 17, 1996A case for a compact disc comprises two hinged parts adapted to house a compact disc. One of the parts defines a base which includes a spindle on which the compact disc may be mounted. The other hinged part defines a lid. A catch mechanism, including a button on one of the hinged parts is adapted to interact with the other hinged part and is resiliently mounted on a stem to latch in a snap-fit action with the other hinged part. A resilient biasing element is formed on the base and is disposed adjacent the stem and acts to bias the two hinged parts apart. Depression of the button by a user unlatches the two hinged parts and thereby opens the case. The button is recessed so that the upper surface of the button does not project substantially beyond the planar surface of the lid when the case is closed.
Patent JP-2001508160-A (JP)
Title: 可撓性カプラ装置
IPC: F16L11/12
Filed: 1998-01-06
Abstract: (57)【要約】
車両の排気系において連続長の流体伝送部材を接合するための可撓性カプラ装置（１１０）である。パイプ内側部材が、それぞれの隣接したパイプ端に取り付けた２つのパイプ・アダプタ部材（１１４、１１５）の隣り合った端に挿入される。第１のスペーサ部材（１２５）が、アダプタ部材のうち一方のアダプタ部材（１１４）の端とパイプ内側部材との間に半径方向、軸線方向に閉じ込められる。第２のスペーサ部材（１２６）が、アダプタ部材のうち他方のアダプタ部材（１１５）の端とパイプ内側部材との間に半径方向に、軸線方向に閉じ込められる。可撓性の、伸張性があるシール部材（１３０）がアダプタ部材（１１４、１１５）を、そして、順次にパイプ端を機械的に接続する。片寄せ手段（１４０）が設けてあって、カプラ装置（１１０）に軸線方向バイアスあるいは予荷重を与え、カプラ装置（１１０）の圧縮に対して漸進的な抵抗を与える。
Patent JP-2001502608-A (JP)
IPC: B21F35/00
Filed: 1998-01-22
Abstract: PCT No. PCT/SE98/00092 Sec. 371 Date Oct. 30, 1998 Sec. 102(e) Date Oct. 30, 1998 PCT Filed Jan. 22, 1998 PCT Pub. No. WO98/32555 PCT Pub. Date Jul. 30, 1998A device for the manufacture of elastic springs for spring interior mattresses, vehicle cushions, cushions and the like. The springs are constructed from a row of continuous, spiral shaped parts arranged after each other. The device comprises a feeding tool (18) for the spring wire (6), a bending tool (20) for the wire adjustable in a plane essentially perpendicular to the feed direction of the wire, and a spring shaping tool (21), which can consist of two parallel plates between which the wire runs during the manufacturing of the spiral shaped parts of the elastic spring and which are turnable for the adjustment of the slope angle of the spring part. At least one gear transmission (22), which especially can be a planetary transmission, is arranged for the adjustment of the spring shaping tool (21) in predetermined rotational positions. The adjustment tools (21, 42) are arranged for on the one hand the adjustment of the angular position of the bending tool (20), and on the other hand for the performance of the predetermined bending operations.
Patent JP-2000506973-A (JP)
IPC: C12N15/10
Filed: 1997-03-12
Abstract: A method of identifying antigens which are capable of being endogenously processed by a cellular secretory pathway comprising: introducing an antigen into a donor cell lacking in MHC class I molecules, incubating in an in vitro medium the donor cells, primed cytotoxic T lymphocytes having specificity for the antigen, and target cells which express MHC class I molecules and are labelled with a detectable intracellular marker, under suitable conditions such that the donor cells remain intact, and measuring the amount of detectable marker released into the incubation medium. A method of assaying a medium for the presence of a substance that affects processing of an endogenously processed antigen in a cellular secretory pathway, and; a method of characterizing a tumor or viral antigen capable of being endogenously processed by a cellular secretory pathway.
Patent JP-H11504595-A (JP)
Title: 閉鎖装置
IPC: G02B6/24
Filed: 1996-04-23
Abstract: (57)【要約】
第１及び第２部分を閉鎖するためのオーバーセンター閉鎖装置は、第１部分に回動自在に設けられ、腕部に回転自在に取り付けたレバーで構成され、該レバーは、第２部分に係合する係合面を有し、使用時、オーバーセンター位置にあるとき、２つの部分を締結し、係合面を越えて伸びる伸長部を有し、閉鎖の初期段階で初期閉鎖てこ作用をもたらすように第２部分と協働し、係合面を閉鎖の最終段階で最終閉鎖てこ作用をもたらすように第２部分に接触させる。
Patent JP-2000509077-A (JP)
Title: チエニル―及び／又はチアゾールアゾ染料を含有する染料混合物
IPC: B41M5/39
Filed: 1997-03-10
Abstract: (57)【要約】
アミノチアゾール−、アニリン−又はテトラヒドロキノリン系から成るカップリング成分を有するチエニル−及び／又はチアゾールアゾ染料１種又は数種、その最高吸収を４１０〜５２０ｎｍの波長で有するモノアゾ−又はジスアゾ染料、メチン染料、アザメチン染料、アントラキノン染料、ニトロ染料又はキノフタロン染料の群からの染料１種又は数種、並びに、場合により、その最高吸収を６００〜７００ｎｍの波長で有するモノアゾ−又はジスアゾ染料、メチン染料、アザメチン染料、アントラキノン染料、ニトロ染料又はキノフタロン染料の群からの染料１種又は数種（この際、最高吸収の半価幅は少なくとも２０００ｃｍ -1 である）を含有する染料混合物、この染料混合物の熱転写法、並びに合成物質の染色又は印刷のためのその使用。
Patent JP-H11506333-A (JP)
Title: 有機溶液における酵素触媒作用
IPC: C12N9/96
Filed: 1996-06-03
Abstract: (57)【要約】
有機酵素溶液が酵素および界面活性剤のイオン対複合体、ならびに、その中に酵素−界面活性剤イオン対が溶解される有機溶媒を含有し、この溶液は等量の酵素およびイオン対複合体を含有しない有機溶媒の懸濁液より少なくとも１桁高い触媒活性を有する。酵素は、好ましくはアシルトランスフェラーゼ活性を有するヒドロラーゼであり、そして界面活性剤は低濃度のAerosol OT（ビス(2-エチルヘキシル)スルホスクシネートナトリウム）である。有機酵素溶液は、最大酵素活性のpHの酵素の水溶液を得ること、イオン性界面活性剤をイオン対を形成するに十分な量で水溶液に添加すること、ならびに、酵素−界面活性剤イオン対を逆ミセルの実質的な形成なしに有機溶媒相中に抽出して、有機溶媒中に溶解された酵素−界面活性剤イオン対を含む無水有機酵素溶液を生成することにより（その結果酵素が天然構造および実質的な触媒活性を保持する）、作製され得る。本発明による触媒溶液は、アシル供与体および求核剤からのペプチド合成を触媒するために使用され得る。
Patent JP-2000512089-A (JP)
Title: 合成ビデオ信号を復号化するための方法および装置
IPC: H04N9/66
Filed: 1997-04-14
Abstract: (57)【要約】
水平偏差と垂直偏差と時間偏差にしたがってピクセルごとに選択された分離フィルタを用いて、合成ビデオ信号は、クロミナンスとルミナンスに分離される。副搬送波領域内の信号は、相補的なクロミナンスフィルタパスとルミナンスフィルタパスを通過し、各パスは、レート変換器とシンクロナイザを含む。クロミナンスフィルタパスにおいて、復調されたクロミナンスに対して動作するクロミナンス／クロスカラー分離フィルタが、クロスカラーを分離し、このクロスカラーは、ルミナンスフィルタパスの出力と組み合わせる前に変調器を通過し、復調器からの情報が、再変調器で用いるために転送される。
Patent JP-2001519914-A (JP)
Title: トルクおよび角位置複合型センサ
IPC: G01L3/12
Filed: 1999-01-28
Abstract: (57)【要約】
トルクおよび角位置複合型検出器は、同軸を中心に回転可能な２枚のディスク（１０，１２）を備える。トルクが印加されると、ディスクの相対的角変位が生じる。各ディスクは、異なる光透過率を有する多数の領域を備え、これらの領域により光源（２０）からアレイ（２２）への光放射の透過を制御する。アレイ（２２）上には、これらのディスク領域の像が形成される。データプロセッサ（２４）は、像の強度データを処理し、ディスクの角位置とそれらの相対変位とを測定する。(i)一方のディスクの円周方向で変化する幅を有し、中間的な透過率を有する一方のディスク領域を設ける、(ii)一方のディスクの円周方向で変化する幅を有してより低い透過率を有する領域を設ける、または(iii)一方のディスクの円周方向でいくつかの異なる幅を有する領域を組み合わせて配設する、ことにより位置情報を得る代替構成も記載されている。
Patent JP-H10511257-A (JP)
Title: ビデオデータ復号化装置
IPC: H04N19/625
Filed: 1997-05-13
Abstract: (57)【要約】
可変長復号化により得られたシンボル及びヘッダデータのための復号化装置は、シンボルを受信し、二つの出力端を通してシンボルのブロックを交互に出力するデータ分配器１０，ヘッダデータを受信し、ヘッダデータを解析してシンボルの復元に関わるパラメータを発生するヘッダ解析器５０，前記データ分配器１０から出力されるシンボルのうちイントラマクロブロックのＤＣ係数に関わるシンボルを検出し、検出されたシンボルと前記ヘッダ解析器５０から供給されるパラメータを用いてイントラマクロブロックのＤＣ係数を復元するＤＣ成分復号化手段４０，及び前記データ分配器１０の二つの出力端の一つに個別的に連結され、前記ヘッダ解析器５０により発生されたパラメータ及び前記ＤＣ成分復号化手段４０により発生されたＤＣ係数のうち応ずるＤＣ係数を用いて前記データ分配器１０から入力するシンボルをブロック単位に復元する第１及び第２復元手段２０，３０とを含む。これにより、イントラマクロブロックのＤＣ係数をその他の係数について別の経路で復号することにより、実時間でＤＣ係数を復元することができる。従って、メインプロフィル及び高レベルのビット列を高速で処理できるＭＰＥＧ復号化装置を提供する。
Patent JP-2001516261-A (JP)
Title: 生物分解性の組織開創器
IPC: A61B17/08
Filed: 1998-03-20
Abstract: (57)【要約】
本発明は、手術中に組織特に内部組織を安定させ且つ引っ張るための新規な方法及び器具を記載している。好ましくは生物分解性の材料からなる絆創膏が組織表面に接着される。この絆創膏を、例えば、鉗子によって直接又は絆創膏に取り付けられた縫い糸を介して操作することにより、組織への傷が最少の状態で組織を引っ張り又は操作することができる。この方法は、最少侵入手術において特に有用である。
Patent JP-2001505761-A (JP)
IPC: C12P21/02
Filed: 1997-05-23
Abstract: Purified and isolated DNA molecule (I) having the 2566, 2084, 2303 or 1795 bp nucleic acid sequence given in the specification, is new.
Patent JP-2001523959-A (JP)
Title: 疾患のリボザイム処置のための物質および方法
IPC: A61P9/10
Filed: 1998-04-21
Abstract: (57)【要約】
本発明は、不必要なmRNAを効率的、特異的に減少または除去するための材料および方法を提供する。これらの材料および方法は、網膜疾患のための治療において使用され得る。１つの実施態様において、変異杆状体オプシンmRNAを分解するリボザイムが、網膜色素性変性症または糖尿病性網膜症を処置するために使用される。さらなる実施態様において、一酸化窒素活性に関与するRNAを切断するリボザイムが、血管網膜機能障害を処置するために使用される。好ましい標的としては、VEGF、eNOS、およびiNOSが挙げられる。
Patent JP-2001524153-A (JP)
Title: 炭化水素をオレフィンと芳香族化合物に転化する方法
IPC: C10G35/095
Filed: 1998-04-08
Abstract: (57)【要約】
例えば、ガソリンのような炭化水素流をオレフィンとトルエン、キシレンのようなＣ 6 〜Ｃ 8 芳香族炭化水素に転化する触媒組成物および方法を開示する。触媒組成物は、ゼオライト、バインダーとボロンを含み、ボロンの重量は約０．０１〜約１０重量％の範囲である。この方法は、炭化水素をオレフィンとＣ 6 〜Ｃ 8 芳香族炭化水素に転化する効果的な条件下で、炭化水素流を触媒組成物に接触させる。また、（１）ゼオライト・バインダー混合物を作成する効果的な条件下で、ゼオライトとコークス還元量のバインダーを混合して、ゼオライト・バインダー混合物を作成し；（２）ボロン混合または含浸ゼオライトを作成する効果的な条件下で、前記ゼオライト・バインダー混合物とコークス還元量のボロン化合物を接触させて、ボロン混合または含浸ゼオライトを作成し；そして（３）ボロン混合または含浸ゼオライトを焼成することより成る触媒組成物の製造方法を開示する。
Patent JP-2001526823-A (JP)
Title: 電子ビーム開口要素
IPC: H01J37/09
Filed: 1998-05-14
Abstract: (57)【要約】
電子ビーム開口要素（１０）は、電子ビーム（Ｅ）のための通路（１２）と、当該通路を通る以外のビームの一部又は全ての進行を阻止するための阻止表面（１５）とを備えた本体（１１）を有して構成される。阻止表面（１５）は、通路の軸線（１３）から離れ特に上記表面（１５）と遮蔽部材（１７）の壁とによって境界を付けられた電子トラップ窪み部（２１）内に向けられるべき阻止されたビーム又はその一部から出た離脱電子を生じるように角度を付けられている。上記壁は窪み部（２１）へ戻る再方向付けのために電子を阻止表面（１５）に戻し、それゆえ散乱電子の逃げを防ぎ、あるいはその逃げを、上記要素を装着した電子ビームコラムの内部環境にとって大部分安全にするように十分な吸収が起こるまで、遅らせる。
Patent MX-146192-A (MX)
Inventor: MESCHKAT URSULA
IPC: C11D1/835
Filed: 1976-06-30
Abstract: Disclosed is a liquid fine washing agent, which, in addition to good washing properties, has an excellent fiber-caring effect and, in particular, bestows a soft feel to textiles treated therewith. The washing agent achieving these objectives contains about 7 to 40% by weight of at least one nonionic surface-active agent, especially at least one C10-C20-alkylpolyglycol ether and/or C6-C20-alkylphenolpolyglycol ether; about 3 to 15% by weight of at least one C8-C20 fatty acid polyglycol diester; and about 1 to 7% by weight of a quaternary ammonium compound with textile-softening properties, especially a di-C10-C22-alkyldimethyl or - ethylammonium halide.
Patent MX-150645-A (MX)
Inventor: AKESSON YNGVE REINHOLD
IPC: A23N15/04
Filed: 1980-11-12
Abstract: The invention relates to a device in a machine for trimming vegetables, especially Brussels sprouts, by means of a rotary cutter forming the bottom of a trapezoidal groove (3), which is formed by the inclined sides (2) of a pair of rotary flanges, the vegetables being caused by the action of the rotary flanges and stationary holding means (5-12) to perform a rotary movement around themselves at the same time as they follow the rotary flanges in the groove (3) between them, and projecting parts of the vegetables are exposed to the cutter and trimmed off. According to the invention the holding means consists of a number of substantially planar plates (5-12), which are arranged resiliently and elastically pivotable around axes (13-20), which are substantially parallel to the rotary shaft of the cutter and of the flanges, which overlap each other like roof tiles substantially along the groove (3) between the flanges with the free ends of the plates pointing in the direction of rotation, and which form a ceiling of the groove along a part thereof (FIG. 1).
Patent MX-159641-A (MX)
Inventor: LINNELL THOMAS DOUGLAS
IPC: H03H1/00
Filed: 1984-03-29
Abstract: A filter connector (8) for attentuating electromagnetic interference up to 1000 MHz having a housing (10), a filter element (16) enclosed within the housing (10) and electrically conductive pins (18) mounted within the filter element (16). The filter element (16) contains an alumina substrate (42) with thick film layers (44, 50) of a metallization forming pin and ground electrodes, and a dielectric layer (46, 48) separating the electrodes screen printed over the substrate and a glass encapsulant (52, 54). The ground electrode (44) substantially covers a horizontal surface of the substrate (42).
Patent NZ-213759-A (NZ)
Title: Lhrh-ctp protein conjugates influencing prolactin fsh and lh release
Inventor: SEEBURG P H
IPC: C07K14/59
Filed: 1985-10-09
Abstract: DNA encoding a novel polypeptide hormone, designated CTP, has been identified in the human genome. CTP is expressed as a fusion protein (proLHRH) with luteinizing hormone releasing hormone (LHRH), and is post-translationally processed to CTP and LHRH. CTP, its derivatives, and its fusions, including proLHRH, are useful in therapy and diagnostics.
Patent NZ-232524-A (NZ)
Title: Drug formulator chamber, for an iv set, with a flow distributor and a drug delivery device
Inventor: THEEUWES FELIX
IPC: A61M5/14
Filed: 1990-02-14
Abstract: PCT No. PCT/US90/00880 Sec. 371 Date Aug. 12, 1991 Sec. 102(e) Date Aug. 12, 1991 PCT Filed Feb. 14, 1990 PCT Pub. No. WO90/09201 PCT Pub. Date Aug. 23, 1990.An agent formulator (30, 60) for an intravenous administration set (14) is provided. The intravenous administration set (14) includes a container (12) of an IV fluid (13), a drip chamber (22), an agent formulator (30, 60) and an adapter-needle assembly (28). The agent formulator (30, 60) has a fluid inlet (23) and a fluid outlet (25) for maintaining a flow of IV fluid (13 ) therethrough. A portion (36) of the formulator wall (32) is comprised of a window material which allows the agent to diffuse therethrough but which prevents convective loss of the IV fluid (13). A flow distributor (38, 68) is provided within the chamber for distributing the flow of IV fluid (13) along the interior surface of the window (36). A transdermal-type drug delivery device (40) is adhered to the exterior surface of the window (36). Drug is delivered by the delivery device (40) through the window (36) and into the flowing IV fluid (13). The device (40) delivers drug into the IV fluid (13) at a rate that is independent of the flow rate of IV fluid (13) through the formulator (30, 60). The rate of drug delivery from the device (40) into the IV fluid (13) is controlled by either the window (36) itself or by a membrance layer (46) in the drug delivery device (40). A plurality of drug delivery devices (40) may be adhered to the window (36) to deliver a plurality of drugs or to deliver a single drug at a higher dosage rate. A similar window (11) may be placed in a IV bag to deliver a drug into the IV fluid therein.
Patent NZ-237546-A (NZ)
Title: Preparation of (1s)-1-(n-(4-0-deacetyl-23-vinblastinoyl) amino)-2-methylpropyl diethyl phosphonate
Inventor: THEVIGNOT ROGER
IPC: C07D519/00
Filed: 1991-03-22
Abstract: Industrial synthesis of (1S)-1-[N-(4-O-deacetyl-23-vinblastinoyl)amino]-2-methylpropyl diethyl phosphonate and its salts by condensation of 4-O-deacetylvinblastinoic acid (obtained by alkaline hydrolysis of vinblastine sulphate) with phosamine (+) (dextrorotatory isomer of 1-amino-2-methylpropyl diethyl phosphonate), by means of BOP, a peptide coupling reagent, [1-benzotriazolyloxytris(dimethylamino)phosphonium hexafluorophosphonate]; and, if desired, the product obtained is converted into a salt with suitable acids.
Patent NZ-238369-A (NZ)
Title: Citric salt of 3-((5-methyl-2-furanyl)-methyl)-n-(4-piperidinyl)-3h-imidazo(4,5-b)pyridin-2-amine(noberastine)
Inventor: DE KNAEP ALFONS GASTON MARIA
IPC: A61K31/4188
Filed: 1991-05-31
Abstract: <CHEM> 3-[(5-methyl-2-furanyl)methyl]-N-(4-piperidinyl)-3H-imidazo[4,5-b]pyri din-2-amin e 2-hydroxy-1,2,3-propanetricarboxylate, a novel salt having satisfactory physicochemical stability and useful antiallergic activity. Compositions comprising said novel salt, processes for preparing and purifying said salt and a process for preparing said compositions.
Patent NZ-258592-A (NZ)
Title: Taxane derivatives and medicaments: intermediates
Inventor: BOUCHARD HERVE
IPC: C07D305/14
Filed: 1993-12-07
Abstract: New taxoids of general formula (I), their preparation and pharmaceutical compositions containing them. In general formula (I), Ar represents an aryl radical, R represents a hydrogen atom or an acetyl, alkoxyacetyl or alkyl radical, R<SUB>1 </SUB>represents a benzoyl radical or a radical of formula R<SUB>2</SUB>-O-CO- in which R<SUB>2 </SUB>represents an optionally substituted alkyl radical, an alkenyl, alkynyl, cycloalkyl, cycloalkenyl, bicycloalkyl, phenyl or heterocyclyl radical. The new products of general formula (I) have a remarkable antitumor activity.
Patent NZ-260559-A (NZ)
Title: Asynchronous cell mode data transmission
Inventor: GASS RAYMOND
IPC: H04L12/56
Filed: 1994-05-20
Abstract: Method and arrangement intended to allow transmission, via a link operated in cell mode between two telecommunication installation units, of information previously supplied to one of the two units via a link in narrow band circuit mode, when the two units are respectively managed in circuit mode. The arrangement for implementing the method according to the invention involves the implementation of at least two combined units (3) linked, on the one hand, together by a link for cell mode and, on the other hand, each linked to a unit and/or to terminals, supporting the circuit mode. Each combined unit includes a communication circuit (9 or 13) for its exchanges in each of the modes, as do the units with which it communicates in one of these modes, and a gateway circuit (14) putting the information modules transmitted by a time-division multiplex link in circuit mode into cell mode in the course of a frame and, conversely, recovery of the information modules contained in a received cell. <IMAGE>
Patent NZ-323274-A (NZ)
Title: Sulfates of 3 alpha, 7 beta-dihydroxy-5 beta-cholan-24-oic acid (UDCA) having improved bioavailability in the gastrointestinal tract
Inventor: SETCHELL KENNETH D R
IPC: A61P1/04
Filed: 1996-11-19
Abstract: Sulfates of 3 alpha, 7 beta-dihydroxy-5 beta-cholan-24-oic acid (UDCA) for use in the treatment of liver disease, inflammatory conditions of the gastrointestinal tract, colon and rectum cancer, a neoplasm of the colon or rectum and combinations thereof. Whereas UDCA is mainly transformed in the liver by conjugation, sulfates of UDCA can be advantageously and effectively delivered to the colon and other portions of the gastrointestinal tract.
Patent NZ-331524-A (NZ)
Title: Piperazine substituted in the 2 position by indolylmethyl and the 4 position by benzylaminoethyl and the method of treating inflammatory disorders
Inventor: JASSERAND DANIEL
IPC: A61K31/496
Filed: 1998-08-24
Abstract: Urea derivatives of the formula 1 are distinguished by properties antagonistic to neurokinin receptors with an action profile beneficial for the treatment of functional and inflammatory disorders of the gastrointestinal tract of large animals where R1 is H or lower alkyl R2 is H or halogen R3 is H or lower alkoxy and a physiologically compatible acid addition salt thereof. Also claimed is a pharmaceutical composition comprising the above formula, process for making and use for treating a pathological condition in which a neurokinin is involved as transfer agent.
Patent NZ-333149-A (NZ)
Title: Brain glycogen phosphorylase tumour rejection antigen precursors including antibodies to and nucleic acids coding them also methods and products for diagnosing and treating conditions characterised by expression of a BGPTR antigen or precursor thereof
Inventor: BRICHARD VINCENT
IPC: A61K38/00
Filed: 1997-06-25
Abstract: Brain glycogen phosphorylase tumor rejection antigen precursors, including nucleic acids encoding such tumor rejection antigen precursors, tumor rejection antigen peptides or precursors thereof and antibodies relating thereto. Methods and products for diagnosing and treating conditions characterized by expression of a brain glycogen phosphorylase tumor rejection antigen or precursor thereof.
Patent NZ-335551-A (NZ)
Title: Improved leaching mineral ores
Inventor: NGUYEN GIAO
IPC: B01F7/00
Filed: 1997-11-06
Abstract: A process for the oxidation of ferrous ions in solution, and more particularly a process for improved base metal and/or uranium leaching from ores, concentrates or tailings using ferric ion as an oxidising agent.  Figure 1: A reaction vessel (10) holds a ferrous ion-containing solution, for example, a copper sulphide leach slurry or concentrate. An agitator (12) may be provided to promote leaching of the base metal into solution. Some of the ferrous ion-containing solution is drawn off from the reaction vessel (10) and pumped through an in-line mixer (14) via a feed pump (16). Oxygen is injected into the reactor (14) to facilitate oxidation of the ferrous sulphate to form ferric sulphate. The ferric ion-containing solution is then recirculated back to the reaction vessel (10) where the ferric ions are reused in the dissolution of copper sulphide into soluble copper sulphate. The two processes of ferrous oxidation and metal leaching can be conducted either simultaneously or sequentially to effect recovery of copper, other base metals or uranium from ores, concentrates or tailings.
Patent NZ-335982-A (NZ)
Title: A foldable agricultural machine, as well as a method of folding same from the working position into the transport position
Inventor: VAN DEN ENGEL ALFONSUS JACOBUS
IPC: A01D78/10
Filed: 1998-09-09
Abstract: Disclosed is an agricultural machine which can be brought from the working position into the transport position, which agricultural machine is provided with a frame (3) comprising a number of motor-driven working members (5) that are located, in the working position of the machine, in side by side relationship transversely to the usual direction of travel, the machine being provided with pivoting means, so that at least one of the working members is pivotable into the transport position about a first pivotal axis (16) which, in the working position of the machine, is orientated at least substantially horizontally and at least substantially perpendicular to the usual direction of travel of the machine and about a second pivotal axis (13) which is orientated transversely to the first pivotal axis, and which machine is provided with control means for controlling the angle of pivoting, these control means ensuring that said working member pivots into the transport position through at least approximately 45o about the first pivotal axis.
Patent NZ-501285-A (NZ)
Title: Process for preparing 4-(4'-fluorophenyl)-3-(3', 4'-methylenedioxy-phenyl)-piperidine
Inventor: YU MARVIN SUNGWHAN
IPC: A61P25/28
Filed: 1998-05-29
Abstract: Compounds of structure (1) are obtained by reduction of compounds of the structures (2a), (2b), (4a), (4b). Compounds of structure (1) in which R is hydrogen or an alkyl, aralkyl, aryl, acyl, alkoxycarbonyl, arylalkoxycarbonyl, aryloxycarbonyl group and especially where Z is a hydrogen atom or a 3,4-methylenedioxyphenyl group, are important intermediates for inter alia paroxetine.  Disadvantages in the existing processes for preparation of such compounds are overcome, and so an alternative processes for their manufacture is provided. Paroxetine is the (-) trans isomer of 4-(4'fluorophenyl)-3-(3',4'-methylenedioxy-phenoxymethyl)-piperidine.  This compound is used in therapy as the hydrochloride salt to treat inter alia depression, obsessive-compulsive disorder (OCD), Parkinson's disease and panic.
Patent NZ-502951-A (NZ)
Title: Gene coding for androctonine and Protein 1A from tobacco (Nicotiana tabaccum)
Inventor: FREYSSINET GEORGES
IPC: C07K19/00
Filed: 1998-08-18
Abstract: A nucleic acid fragment encoding for androctonin, a chimeric gene comprising a coding sequence linked to heterologous 5' and 3' regulatory elements, where the coding sequence comprises at least one DNA fragment coding for an androctonin; a cloning or expression vector containing the chimeric gene, a transformed host organism, especially a plant cell, containing the chimeric gene and plants comprising transformed plant cells and seeds are also described.